基于Rab21的向纳米药物输送系统的FFPG,以有效地输送帕克利塔克塞尔来抑制肺癌的进展
Jing Wang1,2, Xueying Yan1, Wenfei Wang3
1Key Laboratory of Basic and Application Research of Beiyao (Heilongjiang University of Chinese Medicine), Ministry of Education, 24 Heping Road, Harbin 150040, China.
Pharmaceutics
|January 25, 2025
概括
这项研究开发了一种使用Platycodon grandiflorus fructans (FFPG) 的新型纳米药物递送系统 (NDDS),以增强用于肺癌治疗的Paclitaxel (PTX) 递送,改善向和抗瘤疗效.
科学领域:
- 药理学 药理学是指药理学的学科.
- 生物技术是生物技术.
- 在瘤学瘤学.
背景情况:
- 普拉提科登 (Platycodon grandiflorus,简称PG) 是一种传统的中医药,用于治疗肺部疾病.
- 以前已经确定了来自PG (FFPG) 的果糖和果糖.
- 一个纳米药物递送系统 (NDDS) 已开发用于肺癌治疗.
研究的目的:
- 为了改善帕克利塔塞尔 (PTX) 的脂质体输送.
- 为了增强PTX在肺癌中的抗瘤功效.
- 使用FFPG开发一个针对肺部的NDDS.
主要方法:
- 通过静电吸附来制备FFPG-Lip-PTX NDDS.
- 使用动态光散射,泽塔电位和TEM进行表征.
- 在体外和体内对药物输送,细胞毒性,细胞亡,迁移,入侵和抗瘤效应的评估.
主要成果:
- FFPG-Lip-PTX显示出均的颗粒大小,高封装效率和稳定性.
- FFPG增强了瘤细胞的NDDS吸收,增加了细胞毒性和抗瘤作用.
- 在体内研究证实了显著的肺癌向和抗瘤活性.
结论:
- 成功开发了一种针对肺部的新型NDDS.
- FFPG-Lip-PTX增强了肺癌化疗药物的治疗效果.
- 这种NDDS显示出改善肺癌治疗的潜力.
相关概念视频
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
Drugs that Stabilize Microtubules
2.0K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.0K


